GT Biopharma logo
GT Biopharma GTBP
$ 3.12 78.8%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

GT Biopharma Operating Cash Flow 2011-2024 | GTBP

Annual Operating Cash Flow GT Biopharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-8.85 M -15.2 M -15.6 M -7.26 M -3.66 M -10.7 M -5.43 M -1.93 M -4.66 M -1.75 M -442 K -987 K -963 K

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-442 K -15.6 M -5.96 M

Quarterly Operating Cash Flow GT Biopharma

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - -4.16 M - - - -2.91 M - -10.9 M -8 M -5.22 M - -11.9 M -7.97 M -3.68 M - -5.34 M -3.63 M -223 K - -3.17 M -2.05 M -961 K - -9.43 M -6 M -4.23 M - -3.28 M -1.04 M -650 K - -1.8 M -1.23 M -167 K - -3.71 M -3.08 M -1.79 M - -711 K -133 K -90 K - -73 K -118 K -138 K - -773 K -495 K -192 K - -639 K -540 K -147 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-73 K -11.9 M -2.91 M